Table 1.

Patient characteristics

DiagnosisSexAge, yKaryotypeOther relevant mutations
AML M6a 77 46,XY,del(5)(q22q34),+8,dic(15;17)(p11;p11),der(20;21)(p10;q10),+der(20;21)(p10;q10) [16] DNMT3A, TP53 
AML M6a 48 46,XY,del(11)(p11p14) [11] 46,XY [9]  
AML M6 74 48,XY,+8,+8 [4] 48,XY,der(6)t(6;6)(p25;q12),+8,+8 [15] 46,XY [1] DNMT3A, RUNX1, TP53 
AML M6 81 46,XX,t(4;10)(q13;p12) [3] 45,XX,t(4;10)(q13;p12),del(5)(q31q35),-7 [3] 46,XX [4] TET2, TP53 
AML M6 71 47,XY,+8 [10] 46,XY [10] ASXL1 
AML M6 42 46,XX[20] FLT3 TKD, NPM1 
AML M6 49 46,XX[20] NPM1 
AML M6 56 46,XX[20] NPM1 
DiagnosisSexAge, yKaryotypeOther relevant mutations
AML M6a 77 46,XY,del(5)(q22q34),+8,dic(15;17)(p11;p11),der(20;21)(p10;q10),+der(20;21)(p10;q10) [16] DNMT3A, TP53 
AML M6a 48 46,XY,del(11)(p11p14) [11] 46,XY [9]  
AML M6 74 48,XY,+8,+8 [4] 48,XY,der(6)t(6;6)(p25;q12),+8,+8 [15] 46,XY [1] DNMT3A, RUNX1, TP53 
AML M6 81 46,XX,t(4;10)(q13;p12) [3] 45,XX,t(4;10)(q13;p12),del(5)(q31q35),-7 [3] 46,XX [4] TET2, TP53 
AML M6 71 47,XY,+8 [10] 46,XY [10] ASXL1 
AML M6 42 46,XX[20] FLT3 TKD, NPM1 
AML M6 49 46,XX[20] NPM1 
AML M6 56 46,XX[20] NPM1 

F, female; M, male.

Close Modal

or Create an Account

Close Modal
Close Modal